Nutraveris, a software firm that consults on regulatory affairs for nutrition and dietary supplement markets in Europe, has announced that they have launched an online platform for supplement compliance in the United States.
A new paper from a prominent industry critic has found a number of unapproved drugs in a suite of cognitive and memory support products purchased online.
Testing done by supplement manufacturer Nature’s Way and publicized by the American Botanical Council further solidifies the notion that adulteration of elderberry products is on the rise.
A ‘Regulatory Gap’ exists within the US dietary supplements industry, and recent talk of modernizing the regulations are ways to close that gap, FDA’s Steven Tave said yesterday
The recent upheavals in the United States around race relations has the nation questioning the insidious role prejudice has played in many walks of life. One group is seeking to use that rekindled awareness as added leverage to ensure equal opportunity...
Dietary supplement manufacturer Pharmavite has filed a RICO lawsuit against the Clean Label Project, alleging that the organization’s testing and product grading activities amount to a protection racket.
A nonprofit group has asked FDA to crack down on the sale of tianeptine, an ingredient that is sold as an antidepressant drug in many markets outside of the United States.
An inspection and review conducted by South Korea’s authorities found that most of the supplements of questionable quality being sold only were from US brands.
The hemp/CBD industry may have gotten the cart before the horse in terms of extraction capacity and raw material supply, said an investment analyst familiar with the sector.
An upcoming symposium will explore the toxicology, pharmacokinetics, analysis, and regulatory perspectives of pyrrolizidine alkaloids, toxic compounds that may be found in food and herbal products.
Interest in personalized nutrition is surging, increasing more than threefold between 2017 and 2019. With more than a billion people worldwide diagnosed with diet-related diseases, costs for their care has jumped to more than $1 trillion dollars a year....
Nascent hemp/CBD firms are often woefully unprepared for the regulatory compliance side of operating a dietary supplement firm, something an upcoming industry event aims to help fix.
